awards grant
- A Phase I Trial of Tazemetostat Combined with Venetoclax in Patients with Relapsed/Refractory NHL
- A Phase Ib trial of tazemetostat plus mosuntezumab in untreated follicular lymphoma
- Epigenetic basis and therapeutic interdiction of FL progression
- Lymphoma Scientific Research Mentoring Program (LSRMP)
- Precision epigenetic therapy for SETD2+/- B cell lymphomas
- Understanding and targeting metabolic rewiring in therapy-resistant B cell lymphomas
- Understanding the role of SPEN in DLBCL